Although these results might reflect translocation of binding proteins from cytoplasm to nucleus, other interpretations must be considered since we often observed an increase, rather than the expected reduction, in cytoplasmic retinoid-binding protein levels.
S
EVERAL studies support the view that retinoic acid (RA) t promotion of differentiation of embryonai carcinoma (EC) cells is mediated by cellular RA-binding protein (CRABP) Sherman et al., 1983a; Schindler et al., 1981; McCue et al., 1983 McCue et al., , 1984a Wang and Gudas, 1984) . Evidence has been presented from studies with [3H] RA that the RA-CRABP holoprotein interacts specifically with nuclei in vivo (Wiggert et ai., 1977; and Bok et al. (1984) have detected CRABP with specific antiserum in nuclei of freshly dissected retinal cells. Mehta et al. (1982) , Cope et al. (1984a) , and Takase et al. (1986) have described the interaction in vitro between CRABP holoprotein and nuclei from mammary carcinoma and testicular cells. In an abstract McCormick et al. (1984) stated that nuclei from F9 EC cells could also bind [3H]RA-CRABE In this study, we have undertaken further characterization of the interaction between RA-CRABP and EC cell nuclei. Because RA can promote differentiation of HL-60 promyelocytic leukemia cells even though these cells have little or no CRABP (Douer and Koetfier, 1982) , and because Chou et ai. (1983) have claimed that RA interacts specifically with HL-60 nuclear components, we have also examined the interaction of free RA with EC nuclei.
Retinol promotes differentiation of some EC cells but it is substantially less potent than RA (Eglitis and Jetten and De Luca, 1983) . In addition to CRABP, EC cells possess CRBP, a binding protein for retinol (Matthaei et ai., 1983) . Chytil and his colleagues (Takase et al., 1979; Liau et al., 1981) and Cope et al. (1984a) have thoroughly described the interaction between retinol-CRBP and nuclei from rat testis and liver. Liau et al. (1981 Liau et al. ( , 1985 have provided evidence that the retinol-CRBP complex interacts specifically with chromatin components and that at some point the complex dissociates, leaving the ligand, but not the apoprotein, tightly adherent to some nuclear site(s). Since both RA and retinol might, therefore, be translocated to nuclei via their binding proteins, we have compared the interaction between RA-CRABP and retinol-CRBP with EC nuclei as a first step in determining whether differences in binding characteristics could explain the marked margin of potency between retinol and RA as inducers of differentiation.
Materials and Methods

Cell Cultures
Nulli-SCC1 and PCC4.azalR are EC cell lines that differentiate readily in response to RA . Nulli-SCC1 cells differentiate to a modest extent in response to retinol, whereas this retinoid fails to induce differentiation of PCC4.azalR cells and is toxic to the cells during treatment for more than a few days at concentrations at or above 8 x 10 -7 M (Eglitis and . Cells were maintained in DME supplemented with 10% heat-inactivated FCS, extra glucose and glutamine, and antibiotics; Nulli-SCC1 cells were cultured on gelatin-coated substrata (see for further details of the characteristics and culture conditions of these cells). To obtain nuclei for in vitro retinoid-binding protein assays, cells were cultured in 600-cm 2 Nunclon plates (Gibco, Grand Island, NY) and harvested when the cell density reached 5 x 107-3 x l0 s per plate. To evaluate the effects of retinoids on nuclear retinoid-binding activity, cells were cultured for at least 5 d in medium containing 10% FCS delipidated with diisopropyl ether (Chain and Knowles, 1976) . We have previously determined that this procedure removes at least 95 % of added labeled retinol or RA (Sherman et al., 1983a) . Retinoids were added to the culture medium at 2 x l0 -a M in 0.1% ethanol 2 h before harvesting the cells. Control cultures were treated with ethanol alone.
Preparation of Nuclei
Nuclei were isolated by the method of Liau et al. (1981) . Briefly, cells were washed with PBS, trypsinized, collected by low speed centrifugation, and washed once more with cold buffered saline. All subsequent procedures were carried out at 4°C and in the presence of 0.25 ~tM phenylmethylsulfonylfluoride to minimize protein degradation. Cells were homogenized in 0.87 M sucrose in TKDM (50 mM "Iris HCI pH 7.5, 25 mM KCI, 0.5 mM DTT, and 4 mM MnCI2) and centrifuged at 12,000 g for 30 rain. The supernate was centrifuged at 105,000 g for 90 rain and extensively dialyzed against TPN25 (25 mM Tris HCI pH 7.5, 25 rnM NaH2PO4, 25 mM NaC1) to yield the cytosol fraction. The 12,000 g nuclear pellet was resuspended by gentle homogenization in 0.87 M sucrose in TKDM, and centrifuged at 95,000 g for 75 rain in a swinging bucket rotor (model SW28; Beckman Instruments, Inc., Palo Alto, CA) between a pad of 2 M sucrose and an overlay of 0.3 M sucrose, both in TKDM buffer. The pellet was resuspended in 1.8 M sucrose in TKDM, centrifuged at 18,000 g for 30 rain, and washed with 0.3 M sucrose in TKDM. For in vitro studies, the resultant purified nuclei were resuspended in 0.3 M sucrose in TKDM and used immediately. For determination of intrinsic retinoid-binding activity, the nuclei were centrifuged at 800 g for 10 rain, resuspended in TPN25, and frozen. After thawing, the extracts were sonicated for 3 rain and centrifuged at 147,000 g for 90 rain (model SWS0 rotor; Beckman Instruments, Inc.) to generate nucleosolic extracts.
The purity of isolated nuclei was confirmed by light and electron microscopy.
Preparation of Retinoid-binding Proteins
Tumor tissue generated in mice by the injection of PCC4.azalR EC cells (106 cells per mouse) served as a source of retinoid-binding proteins. The procedure used was based upon that described by Ong and Chytil (1980) . Pooled tumor tissue (250-300 g) was homogenized in 2 vol of 50 mM Hepes buffer, pH 7.5. The homogenate was cleared by centrifugation for 30 min at 30,000 g. The supernate was brought to pH 5.0 by dropwise addition of glacial acetic acid, centrifuged, and the resultant supernate was readjusted to pH 7.5 with 1 N NaOH. A 40-75 % ammonium sulphate cut was obtained and dialyzed against 50 mM Tris, pH 7.5, plus 200 mM NaCI. 10 lxCi each of [3H]RA and [3H]retinol (both at 20-30 Ci/mmol) were added and the preparation was kept overnight at 4°C. The labeled material was then applied to a Sephadex G-75 column (12 x 75 cm) and eluted with the same buffer. The two retinoid-binding proteins coeluted between 880 and 1,070 ml. After regeneration of apoproteins by exposure to fluorescent light (5 h at 4°C), the crude binding protein preparation was dialyzed against 25 mM Tris, pH Z5, plus 25 mM NaC1, labeled again with 5 gCi each of [3H]retinol and [3H]RA, and applied to a Bio-Gel HTP hydroxylapatite column (2.5 × 40 cm). The column was eluted with a gradient of 0-120 mM sodium phosphate in the same buffer. This chromatographic procedure successfully separated the two binding proteins, as could be demonstrated by light inactivating the bound retinoids and, after dialysis, recharging with either [3H]retinol or [3H]RA. CRBP activity was eluted at 70 mM phosphate whereas CRABP activity was recovered at 90 mM phosphate. As demonstrated in Table I , no cross-binding of labeled retinoids was observed. The CRBP and CRABP preparations were dialyzed against TPN25, concentrated to ,,ol mg/ml, and stored at -70°C. When the binding protein preparations were analyzed by SDS PAGE, both contained prominent peaks at ,-ol5 kD as expected. Unidentified bands were observed at ~20 and 30 kD (not shown); the latter might represent dimerized binding protein. Subsequent purification steps were not implemented because the partially purified preparations showed complete discrimination of ligand binding and because attempts to further purify the proteins (e.g., by HPLC) resulted in preparations that had little or no capacity for holoprotein regeneration after ligand was removed by exposure to light. For final charging, the binding proteins (1.5 rag) were incubated in 9 ml of TPN25 in the presence of 200 gCi of the appropriate [3H]retinoid or 0.1 lunol unlabeled retinoid. After incubation overnight at 4°C, 1 ml of dextran-coated charcoal (20 mg charcoal and 2 mg dextran-T-70 per ml TPN25) was added, and the solutions were mixed and centrifuged at 1,500 g for 20 min. The supernates were dialyzed in the cold against TPN25. The resultant specific activities of the labeled holoproteins were in the range of 1.5-3.0 × 107 dpm/mg protein.
Association of [3H]Retinoid-binding Proteins with Nuclei
Freshly isolated nuclei were incubated at 20°C for 2 h in an assay mixture (1.25 ml) containing TPN25 plus 250 mM sucrose and 0. 
Binding Protein Measurements
Retinoid-binding protein contents were measured by a procedure adapted from a combination of a previously published Sephadex assay (Sherman et al., 1983a ) and a method used for measuring progesterone receptor (Barkai et al., 1981) . Samples containing 50-200 Ixg of protein in TPN25 buffer were pipetted onto the disk from a Tetralute kit (Ames-Yissum Ltd., Jerusalem, Israel) that was placed on top of a 1 x 2 cm Sephadex G-25 column. For CRABP measurements [3H]RA (3-4 x 105 cpm; 20-30 Ci/mmol), in the absence or presence of a 100-fold molar excess of unlabeled RA, was added in 10 I11 ethanol. The reaction, in a total volume of 300 gl, was carded out for 90 min at 4°C. Column outlets were then opened, the void volume drained, and the bound fraction eluted with 1 ml of TPN25 directly into minivials. CRBP was assayed in the same way except that the labeled retinoid was [3H]retinol and 0.3 M sucrose was included in the assay mixture to reduce background. Each sample condition was measured in triplicate pairs (i.e., with and without unlabeled retinoid). Sephadex columns were regenerated by washing sequentially with 0.1 N HCI, distilled water, 0.1 N NaOH, distilled water, and TPN25. This assay procedure was reproducible and sensitive. Variation among triplicates was on the order of 10 % and day-to-day reproducibility was excellent. Incubation on the disks instead of in tubes did not result in increased amounts of [3H]retinoid binding but led to accelerated reaction rates. The use of fewer counts per minute of labeled retinoid (about one-fifth that in previous studies; e.g., Sherman et al., 1983a) reduced background, thus obviating the need for dextran-charcoal treatment that can lead to displacement of labeled retinoid from its binding protein (unpublished results). As a result, we consistently obtained binding protein specific activities 5-10-fold greater than those observed previously (e.g., Matthaei et al., 1983) .
To measure retinoid-binding activities in nuclei and cytosols of cells pretreated with retinoids, extracts were maintained at 4°C under fluorescent light for 7 h. In previous studies with both crude and purified retinoidbinding proteins, we determined that these conditions were sufficient to remove all previously bound [3H]retinol or [3H]RA from their respective binding protein without detectable loss of binding activity when the samples were rechallenged with appropriate [3H]retinoid. Specific retinoid-binding activities were then determined as described above.
Results
Characterization of the Association of Retinoidbinding Proteins with Nuclei
Binding of [3H]RA-CRABP to PCC4.a~IR and Nulli-SCC1 nuclei was maximal after 30 rain at 20°C and was stable for at least 2 h. Specific binding of [3H]retinol-CRBP to the same nuclei appeared to be slower, reaching a maximum by 2 h. Specific binding was linear in the range of 1-3 x 106 nuclei per assay. In subsequent studies we used 2 x 106 nuclei per assay and an incubation period of 2 h at room temperature, As reported previously by us (Sherman et al., 1985) and by others (Takase et al., 1979; Cope et al., 1984a) , when isolated nuclei were incubated with [3H]RA or [3H]retinol, binding was unsaturable. Although binding was apparently nonspecific, nuclei bound more RA than retinol at similar concentrations of retinoid (Fig. 1 A) . When the same nuclear preparations were incubated with radioactive pH]RA-CRABP or [3H]retinol-CRBP, trapped on filters, and extensively washed, less retinoid was associated with the nuclei (inset, Fig. 1 B) . Furthermore, under these conditions, binding reached a plateau and there was more retinol than RA bound. The amount of radioactive retinoid bound could be reduced by including cold homologous holoprotein in the incubation mixture (Fig. I B) . Similar results were obtained when PCC4.azalR nuclei were used as targets for both binding proteins (not shown). We calculate from our data that the total numbers of specific binding sites in or on Nulli-SCC1 nuclei for RA-CRABP and retinol-CRBP were 1.7 (+0.54) x 105 and 2.4 (+0.71) x 105, respectively. The corresponding numbers for holo-binding protein association with PCC4.azalR nuclei were calculated to be 2.8 (+0.91) x 105 and 5.7 (+1.17) x 105, respectively. Takase et al. (1979) have reported that free ligand failed to compete with [3H]retinol-CRBP for specific sites in liver nuclei, though data were not presented. We have extended these experiments with EC nuclei to include both retinoids 
Effects of Free Ligand on Retinoid Holo-binding Protein Association with Nuclei
Effects of Heterologous Retinoid Holo-binding Protein on Association with Nuclei
To determine whether CRBP and CRABP binding sites on EC nuclei are shared or unique, we carried out competitive binding studies as described in Fig. 1 B except that the unlabeled retinoid holo-binding protein was heterologous. Fig. 3 illustrates that the binding of [3H]retinol-CRBP to Nulli- Binding experiments were carried out as described in Fig. 1 Fig. 1 B) , it can be concluded that RA-CRABP cannot effectively compete for retinol-CRBP sites on NulIi-SCC1 nuclei. Reciprocal experiments illustrate that retinol- CRBP not only failed to reduce [3H]RA-CRABP binding to nuclei but actually potentiated the interaction (Fig. 3) . Qualitatively, this potentiation was reproducibly observed in several independent experiments. The extent of increase in label associated with nuclei varied from three-to ninefold. Similar potentiation was observed with nuclei from PCC4.azalR cells (not shown). The data in Fig. 4 illustrate that the potentiation could be elicited by the retinol holo-binding protein, but not by the apoprotein. As mentioned above and demonstrated in Fig. 2 , free retinol failed to influence the interaction of [3H]RA-CRABP with nuclei; neither was there any effect when retinol was added complexed to BSA or ovalbumin (not shown).
Effects of Triton X-IO0 on Retinoid Holo-binding Protein Interaction with Nuclei
Treatment of isolated nuclei with 0.25-0.5 % Triton X-100 removes the outer nuclear membrane and a substantial proportion of nuclear phospholipids (e.g., Knowles et al., 1973; Liau et al., 1981) . Liau et al. (1981) (Table II) .
Effects of Retinoid Treatment of Intact Cells upon Nuclear and Cytosolic Retinoid-binding Activities
It has been shown that a 2-h exposure is adequate for movement of [3H]RA or [3H]retinol into the nuclear compartment in EC cells Sherman et al., 1985) . To evaluate the effects of exposing cells to retinoids upon specific retinoid-binding activities, we cultured Nulli-SCC1 or PCC4.azalR cells for 5 d or more in medium depleted of retinoids and then treated them with unlabeled retinol or RA for 2 or 5 h. We collected and fractionated the cells and tested cytosolic and nucleosolic extracts for specific retinoid-binding activities. To do this, we exposed the cellular fractions to light under conditions that strip retinoids from their binding protein sites and then incubated aliquots of the extracts with [3H]RA or [3H]retinol with or without a large molar excess of the homologous unlabeled retinoid.
As the data in Table III illustrate, nucleosolic preparations from untreated Nulli-SCC1 cells contained little if any specific RA-or retinol-binding activity. After 2-h exposure of these cells to RA, there was a large (more than 20-fold) increase in specific RA-binding capacity in the nucleosolic extracts. After the cells were treated with retinol, the specific binding of retinol by nucleosols was elevated by more than 40-fold (Table III) . There was, however, a notable difference between the effects of RA and retinol pretreatment on heterologous specific binding activity in nucleosolic extracts: RA had only minimal effects (not statistically significant) on retinol-binding capacity, whereas nucleosols from retinoltreated cells possessed considerably increased RA-binding activity (Table HI) . The same qualitative patterns were observed after cells were preincubated with retinoids for 5 h except that the amount of increase in specific binding activities was in every instance lower than that observed after 2 h retinoid pretreatments (Table HI) . Subnuclear fractions other than the nucleosol were found to possess little or no specific retinoid-binding activity, with or without retinoid pretreatment of the intact cells (not shown).
The above experiments were repeated with PCC4.azalR cells (Table IV) . RA pretreatments affected RA-binding activities in PCC4.azalR nucleosolic extracts in the same way as those in Nulli-SCC1 preparations. The specific retinolbinding ability of PCC4.azalR nucleosols was markedly different from that of Nulli-SCC1 nucleosols: the former preparations contained readily detectable, and essentially unchanged, binding capacities regardless of the retinoid content of the medium in the 2-or 5-h period before collection of the cells (Table IV) . Despite the lack of effect of retinol pretreatment on retinol-binding activity in PCC4.azalR nucleosols, specific RA binding was markedly elevated in response to retinol.
In a series of experiments, we attempted to characterize this specific nucleosolic binding of [3H]RA by sucrose density gradient centrifugation. We consistently observed a heterodisperse radioactivity profile; although there was a clear labeled peak in the 2S region of the gradient, as would be expected for the [3H]RA-CRABP complex, radioactive material also cosedimented with faster moving components. There was no obvious qualitative difference in the radioactivity profiles from extracts of cells pretreated with unlabeled RA or retinol (data not shown). (6) We also measured binding capacities in cytosolic fractions of the ceils. We observed that RA and retinol pretreatment of Nulli-SCC1 cells resulted in increased cytosolic levels of their respective binding proteins. In fact cells exposed for 5 h with either retinoid possessed significantly elevated levels of both retinoid-binding protein activities (Table III) . Some increases in retinoid-binding protein levels were also observed with cytosolic extracts of PCC4.azalR cells, albeit not so consistently as with Nulli-SCC1 cells (Table IV) .
Table III. Binding Activities in Cytosolic and Nucleosolic Extracts of Retinoid-depleted Nulli-SCC1 Cells
Discussion
The experiments described here illustrate that both RA and retinol bind specifically to EC nuclei when introduced via their binding proteins. This finding and our estimates of the number of specific binding sites (1-3 × 105 per nucleus) are consistent with previous reports (Takase et al., 1979; Liau et al., 1981; Cope et al., 1984a; Mehta et al., 1982; McCormick et al., 1984) . Since free retinoids do not show specific, saturable binding to EC nuclei (Fig. 1 A; see also Takase et al., 1979; McCormick et al., 1984; Sherman et al., 1985) , it is logical to conclude that free and holoprotein-bound retinoids do not compete for the same nuclear sites. Fig. 2 illustrates that when the labeled ligand on the holoprotein and the competing free retinoid are the same, there is actually an increase in the amount of radioactivity bound to EC nuclei. A likely explanation is that the unlabeled retinoid can exchange with labeled retinoid on its holoprotein, allowing the freed, labeled retinoid to bind nonspecifically to nuclei in an unsaturable manner. This would explain why excess RA has a substantially greater effect upon displaced [3H]RA binding to nuclei than does unlabeled retinol upon displaced [3H]-retinol binding (Fig. 2) , since free [3H]RA has a greater affinity for nuclei than does free [3H]retinol (Fig. 1 A) .
Pretreatment of liver nuclei with Triton X-100 removed <30% of the specific retinol-CRBP binding sites, indicating that binding-protein-mediated interaction of retinol with these nuclei was unlikely to involve phospholipid or the outer nuclear membrane (Liau et al., 1981) . Our data (Table II) confirm this result and extend it to [3H]RA delivered to EC nuclei via its binding protein. The consequence of exposure of nuclei to Triton X-100 after interaction with [3H]retinol-CRBP was strikingly different, since most of the label was solubilized. The complex between [3H]RA-CRABP and nuclei was consistently more refractory to subsequent detergent treatment. Since the two holoproteins have similar affinities for untreated nuclei (Fig. 1 B) , these results could reflect a different type of nuclear binding site for the two holoprotein-bound retinoids.
We have found that the two holoproteins fail to compete for the same nuclear sites, adding to the view (Takase et al., 1979; Cope et al., 1984a ) that these specific binding sites are different. However, ours is the first observation that retinol-CRBP actually potentiates the binding of [3H]RA-CRABP to nuclei. It is unlikely that the phenomenon we have observed has a trivial explanation, e.g., contamination of the retinol preparation with RA, since only holo-CRBP, not free retinol or apo-CRBP, elicits the potentiation. The elimination of the potentiation of [3H]RA-CRABP binding by pretreatment of EC nuclei with Triton X-100 (Table II) suggests that these binding sites are different from the "basal" [3H]RA-CRABP nuclear binding sites observed in the absence of retinol-CRBP.
The interactions between retinoid-binding proteins and nuclei in vitro, including the potentiation, are paralleled by our findings with intact Nulli-SCC1 EC cells: when cells are pretreated with RA the nucleosols possess specific binding activity, but only for that retinoid; however, when the cells are preincubated with retinol, binding activities for both retinol and RA are readily detected. It must be noted, however, that neither in this study nor in previous ones (Wiggert et al., 1977; has it been proven that the specific retinoid-binding activities in cytosolic and nucleosolic extracts are the same. Indeed, Chou et al. (1983) and Cope et al. (1984b) have reported the presence of nuclear RA-binding proteins whose properties appear to be different from that of the well-characterized CRABP. Such proteins might also be present in EC cells and increase in response to retinoid exposure. Sucrose density gradient analyses failed to clarify this issue since the profiles obtained were heterogeneous. Antisera specific for CRBP and CRABP (e.g., Adachi et al., 1981; Ong et al., 1982; Eriksson et al., 1984) could ultimately be helpful in characterization of the nuclear retinoid-binding activities.
Translocation of binding protein molecules from cytoplasm to nucleus in response to the uptake of retinoids by the cell should be characterized not only by detection of activity in nuclear extracts but also by diminution of cytoplasmic activity. In fact, retinoid treatments commonly resulted in modest, but statistically significant, increases in cytosolic binding protein activities (Tables III and IV) . From the data in Tables III and IV, we calculate that EC cells possess 2-4 x 105 molecules each of CRBP and CRABP (similar to that reported for CRBP in liver cells by Takase et al. [1979] ), and that under optimal conditions only ~104 specific binding sites for [3H]retinol or [3H]RA appear in the nucleosol from each cell (in several attempts we found specific retinoid binding activity only in this nuclear fraction). The loss of such a small proportion of cytoplasmic binding protein molecules in response to retinoid uptake could have escaped detection, especially if retinoid treatments lead to increased total levels of binding proteins.
The presence of constitutive retinol-binding activity in nucleosols from PCC4.azalR cells was unexpected and is unexplained. Unlike other EC lines, PCC4.azalR cells are killed by exposure to relatively low levels of retinol Eglitis and Sherman, 1983) ; we are attempting to determine whether these two observations are related. Although preincubation of PCC4.azalR cells with retinol has no effect on nucleosolic retinol-binding activity, it leads to the appearance of nucleosolic RA-binding activity, as is seen with Nulli-SCC1 nucleosols. Thus the two effects of retinol preincubation appear to be separable.
When incubated for 2 h with 10 -6 M [3H]RA or [3H]retinol, EC cells take up ~2 × 107 and 8 x 107 retinoid molecules, respectively, and 1-2 % of the label (equivalent to r~105-106 retinoid molecules) is detected in purified EC nuclei after treatment with Triton X-100 (Sherman et al., 1983b, 1985, and unpublished observations) . It is therefore notable that if our in vivo studies (Tables III and IV) are detecting translocation of holo-binding proteins from cytoplasm to nucleus, many fewer binding protein molecules (,~104) than ligands are associated with nuclei at any one time. A reasonable explanation for this is the proposal by Liau et al. (1981) and Takase et al. (1986) that the retinoid holo-binding proteins shuttle their ligands to appropriate nuclear sites and then the apoproteins return to the cytoplasm. However, our data do not eliminate the possibility that retinoids not bound to their binding proteins can also reach the nucleus in vivo.
The indication that retinol-CRBP and RA-CRABP have independent nuclear binding sites could explain why RA is considerably more potent than retinol in inducing EC cell differentiation. We find it unlikely that retinol can be convened to RA in amounts adequate to explain the potency of the former retinoid (Eglitis and Gubler and Sherman, 1983) as has been proposed by Williams and Napoli (1985) . However, the observation that retinol-CRBP can potentiate interaction of RA-CRABP with EC nuclei and that incubation of cells with retinol generates specific nucleosolic binding sites for RA suggests that in the presence of retinol very small amounts of RA can become disproportionately effective.
